Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Treatment Period	STARTED	Standard of Care	77
Treatment Period	STARTED	Romiplostim	157
Treatment Period	Received Treatment	Standard of Care	75
Treatment Period	Received Treatment	Romiplostim	154
Treatment Period	Switched to Romiplostim Group	Standard of Care	2
Treatment Period	Switched to Romiplostim Group	Romiplostim	0
Treatment Period	COMPLETED	Standard of Care	60
Treatment Period	COMPLETED	Romiplostim	142
Treatment Period	NOT COMPLETED	Standard of Care	17
Treatment Period	NOT COMPLETED	Romiplostim	15
Safety Follow Up Period	STARTED	Standard of Care	43
Safety Follow Up Period	STARTED	Romiplostim	30
Safety Follow Up Period	COMPLETED	Standard of Care	34
Safety Follow Up Period	COMPLETED	Romiplostim	18
Safety Follow Up Period	NOT COMPLETED	Standard of Care	9
Safety Follow Up Period	NOT COMPLETED	Romiplostim	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00415532/flow